Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This protocol presents a method for generating vascular organoids using human pluripotent stem cells.

Abstract

Vascular organoids derived from human induced pluripotent stem cells (hiPSCs) recapitulate the cell type diversity and complex architecture of human vascular networks. This three-dimensional (3D) model holds substantial potential for vascular pathology modeling and in vitro drug screening. Despite recent advances, a key technical challenge remains in reproducibly generating organoids with consistent quality, which is crucial for downstream assays and applications. Here, a modified protocol is presented that improves both the homogeneity and reproducibility of vascular organoid generation. The modified protocol incorporates the use of microwells and the CEPT cocktail (chroman 1, emricasan, polyamines, and the integrated stress response inhibitor, trans-ISRIB) to improve embryoid body formation and cell survival. Differentiated, mature vascular organoids generated using this protocol are characterized by whole-mount 3D immunofluorescence microscopy to analyze their morphology and complex vasculature. This protocol enables the production of high-quality vascular organoids in a scalable manner, potentially facilitating their use in disease modeling and drug screening applications.

Introduction

In vitro microphysiological models, including organoid and tissue-on-a-chip systems, have emerged over the past decade1,2,3. These three-dimensional (3D), human cell-derived systems address the limitations in conventional two-dimensional (2D) cell culture and animal models, such as the lack of many components in the physiological microenvironment and genetic differences across species, respectively. They provide more physiological insights and are more suitable for disease modeling and drug screening than conventional models. Among the microphysiological models, orga....

Protocol

Figure 1 presents an overview of the steps involved in this protocol. Detailed information regarding the reagents and materials utilized in this protocol is given in the Table of Materials. It is recommended that all the media should be prewarmed at 37 °C before use unless specified otherwise. All the cell culture materials and supplies should be either autoclaved or sterile, and cell handling should be done in a biosafety cabinet. Additionally, the pH value of the coll.......

Representative Results

Figure 1A presents the scheme of this protocol, including the key components used in each stage. The differentiation started with the EB formation, followed by mesoderm induction and vascular lineage specification (Figure 1B-D). The aggregates grew larger and less spherical over time. Organoids started showing rough edges on Day 5. After embedded in the collagen I-basement membrane matrix mixture, vascular endothelial cells and .......

Discussion

The described protocol includes two key modifications for homogenous and reproducible generation of high-quality vascular organoids. The first modification is the use of a microwell plate to enable better control of the EB uniformity. As a starting point of vascular differentiation, the size of EBs is critical as it regulates the stem cell fate and differentiation efficacy towards different lineages. Variations in EB size usually lead to heterogeneous organoids with inconsistent structure and organization

Acknowledgements

We would like to acknowledge the technical support from the Confocal and Specialized Microscopy Shared Resource of Herbert Irving Comprehensive Cancer Center at Columbia University, funded in part through NIH Center Grant (P30CA013696). This work is supported by NIH (R21NS133635, Y.-H.L.; UH3TR002151, K. W. L.). Figure 1A was created using BioRender.

....

Materials

NameCompanyCatalog NumberComments
2-Mercaptoethanol (1000x)Gibco21985023
AccutaseSigma-AldrichA6964
Alexa Fluor 488 AffiniPure F(ab')2 Fragment Donkey Anti-Rabbit IgG (H+L)Jackson Immuno Research Labs711-546-152reconstitute with 0.25 mL 50% glycerol,  store at -20 °C for up to 1 year, dilution ratio for use: 1:1000
Alexa Fluor 647 AffiniPure F(ab')2 Fragment Donkey Anti-Goat IgG (H+L) Jackson Immuno Research Labs705-606-147reconstitute with 0.25 mL 50% glycerol,  store at -20°C for up to 1 year, dilution ratio for use: 1:1000
B27 supplement minus vitamin A (50x)Gibco12587010thaw at 4 °C, aliquot and store at -20 °C, avoid freeze-thaw cycle
BMP4ProSpecCYT-081reconstitute with sterile ddH2O at a concentration of 100 ng/µL, aliquot and store at -20 °C
CD31 antibody abcamab28364dilution ratio: 1:400
CentrifugeEppendorf022626001
CHIR99021Tocris Bioscience4423/10make the stock solution at 12 mM with DMSO, and store at -20 °C for up to 1 year.
Chroman 1Tocris7163/10make the stock solution at 100 µM with DMSO, and store at -20 °C for up to 1 year.
Collagen I Corning40236
Confocal MicroscopeNikonAXRMP/Ti2
Corning Elplasia PlatesCorning4441
Countess II FL automated cell counterThermo FisherAMQAF1000
DMEM/F-12, GlutaMAX supplementGibco10565018
DMEM/F-12, powderGibco12500062make 10x stock solution with biograde ddH2O and sterilize it with a 0.2 µm filter. Store at 4 °C.
Edi042ACedars Sinai
EmricasanMedchemexpress LLCHY1039610MGmake the stock solution at 1 mM with DMSO, and store at -20 °C for up to 1 year.
ERG antibodyCell Singali Technology97249dilution ratio: 1:400
Fetal Bovine Serum - PremiumAtlanta BiologicalsS11150thaw at 4 °C  and aliquot, store at  -20 °C for up to five years, or store at 4 °C for up to a month
FGF2ProSpecCYT557reconstitute with sterile ddH2O at a concentration of 100 ng/µL, aliquot and store at -20 °C
Fluorodish Cell Culture DishWorld Precision InstrumentsFD35-100
ForskolinTocris Bioscience1099reconstitute with DMSO at a concentration of 12 mM, aliquot and store at -20 °C
Gentamicin (50 mg/mL)Gibco15710064
GlutaMAX supplement (100x)Gibco35050061
Heparin, 100 kUMilliporeSigma375095100KUreconstitute with sterile ddH2O at a concentration of 4 kU/mL
HEPES (1 M)Gibco15630080
IncubatorThermo Scientific13998123
Knockout Serum ReplacementGibco10828028thaw at 4 °C, aliquot and store at -20°C, avoid freeze-thaw cycle
Matrigel, GFR Basement Membrane MatrixCorning356230thaw at 4 °C, aliquot and store at -80°C, avoid freeze-thaw cycle
MEM Non-Essential Amino Acids Solution (NEAA, 100x)Gibco11140050
Molecular Biology Grade WaterCorning46000CV
mTeSR plus kitSTEMCELL Technologies1001130thaw at 4 °C, aliquot and store at -20°C, avoid freeze-thaw cycle
N2 supplement (100x)Gibco17502048thaw at 4 °C, aliquot and store at -20°C, avoid freeze-thaw cycle
NaOH solution (1 M)Cytiva HyCloneSH31088.01
NeuroBasal mediumGibco21103049
NIS-Elements, ver 5.42Nikon
Normal Donkey SerumJackson Immuno Research Labs17000121reconstitute with 10 mL sterile ddH2O, store at 4 °C for up to two weeks
paraformaldehyde, 20%Electron Microscopy Sciences15713Sdilute with PBS
PBST, 20xThermofisher28352
PDGFRβ antibodyR&DAF385dilution ratio: 1:400
polyamine supplement (1000x)Sigma-AldrichP8483
Rapiclear clearing reagent, 1.49SUNJIN LABRC149001
Sodium Bicarbonate (7.5%)Gibco25080094
Sodium deoxycholate monohydrateThermofisherJ6228822dissolve with ddH2O for 1% (wt/v) stock solution
TBST, 20xThermofisher28360
trans-ISRIBTocris Bioscience5284/10make the stock solution at 1 mM with DMSO, and store at -20°C for up to 1 year.
Tritin X-100Sigma-AldrichT8787-50ML
Trypan Blue Stain (0.4%)Thermo Fisher15250061
Tween 20Sigma-AldrichP7949-100ML
VEGF-AProSpecCYT-116reconstitute with sterile ddH2O at a concentration of 100 ng/µL, aliquot and store at -20°C

References

  1. Park, S. E., Georgescu, A., Huh, D. Organoids-on-a-chip. Science. 364 (6444), 960-965 (2019).
  2. Takebe, T., Wells, J. M. Organoids by design. Science. 364 (6444), 956-959 (2019).
  3. Griffith, L. G., Swartz, M. A.

Explore More Articles

Bioengineering

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved